Eye Allergy Treatment Market Research Report Information By Type (Seasonal and Perennial Allergic Conjunctivitis, Vernal Keratoconjunctivitis, Atopic Keratoconjunctivitis, Contact Allergic Conjunctivitis, Giant Papillary Conjunctivitis), By Drug Class (Antihistamine, Mast Cell Stabilizer, NASAIDs, Corticosteroid, Decongestants, Immunotherapy Allergy Shots, Others), By Treatment Form (Eyedrops, Injectables, Tablets & Capsules), By Distribution Channel (Hospital Pharmacies, Online Pharmacies and Retail Pharmacies) And By Region Forecast to 2032
Market Overview
In 2022, the market size of cell and gene therapy biomanufacturing was estimated to be USD 12.6 billion. The Cell and Gene Therapy Biomanufacturing market industry is anticipated to witness a compound annual growth rate (CAGR) of 10.60% from USD 13.9 Billion in 2023 to USD 31.2 Billion by 2032 through the forecast period (2024-2032). The primary market drivers that are fostering market growth are the increasing investments in cell and gene therapy research.
The Cell and Gene Therapy Market is experiencing rapid growth, which is driving the Cell and Gene Therapy Biomanufacturing Market forward by increasing demand for manufacturing solutions. Given the promising clinical trial results and the approval of novel cell and gene therapies, there is a growing necessity to increase production in order to satisfy commercialization requirements. The development of efficient, scalable, and cost-effective biomanufacturing processes and infrastructure is required due to the exponential growth of the market. In response to the increasing demand for cell and gene therapy products, biomanufacturing companies are investing in advanced technologies, including automation, single-use systems, and closed-system bioreactors. Furthermore, the Cell and Gene Therapy Biomanufacturing Market is experiencing growth because of the market's expansion, which is fostering collaborations, partnerships, and investments in biomanufacturing capacity to address the swiftly changing cell and gene therapy landscape.
Market Segment Insights
Consumables, Equipment, and Software Solutions comprise the Cell and Gene Therapy Biomanufacturing Market segmentation, with respect to product type.
Based on usage, the market segmentation comprises Commercial Stage Manufacturing and Research Stage Manufacturing.
Based on application, the market segmentation comprises Upstream Processing, Harvesting, and Downstream Processing.
The Cell and Gene Therapy Biomanufacturing Market segmentation is based on the end user and includes Life Science Companies, Contract Research Organizations, Contract Manufacturing Organizations, and Cell Banks.
Regional Perspectives
The study offers market insights for North America, Europe, Asia-Pacific, and the Rest of the World by region. The Cell and Gene Therapy Biomanufacturing Market has been dominated by North America as a result of a variety of factors. Initially, the region is home to a thriving ecosystem of pharmaceutical and biotechnology companies that are actively involved in the research and development of cell and gene therapies. Secondly, the market growth is facilitated by the well-established regulatory frameworks and supportive policies for cell and gene therapy manufacturing in North America.
The second-largest market share in the European Cell and Gene Therapy Biomanufacturing market is attributed to the competent workforce. Several factors have contributed to Europe's acquisition of the second-largest market share in the Cell and Gene Therapy Biomanufacturing Market. The region is fortunate to have a skilled personnel, advanced infrastructure, and a well-established biopharmaceutical industry.
The Asia-Pacific Cell and Gene Therapy Biomanufacturing Market is anticipated to experience the most rapid rate of growth from 2024 to 2032. The Cell and Gene Therapy Biomanufacturing Market is experiencing the highest compound annual growth rate (CAGR) in the Asia Pacific region because of diverse factors. Initially, the biopharmaceutical industry in the region is experiencing accelerated growth because of the growing investment in research and development, particularly in the fields of cell and gene therapy.
Major Players
Lonza Group, Thermo Fisher Scientific Inc., Merck KGaA, WuXi AppTec, Catalent, Inc., Samsung Biologics, FUJIFILM Diosynth Biotechnologies, Charles River Laboratories, Cytiva, Novasep, and Others are the major players in the Cell and Gene Therapy Biomanufacturing market.
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
TABLE 2 GLOBAL EYE ALLERGY TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 3 GLOBAL EYE ALLERGY TREATMENT MARKET, FOR SEASONAL AND PERENNIAL ALLERGIC CONJUNCTIVITIS, BY REGION, 2021–2032 (USD MILLION)
TABLE 4 GLOBAL EYE ALLERGY TREATMENT MARKET, FOR VERNAL KERATOCONJUNCTIVITIS, BY REGION, 2021–2032 (USD MILLION)
TABLE 5 GLOBAL EYE ALLERGY TREATMENT MARKET, FOR ATOPIC KERATOCONJUNCTIVITIS, BY REGION, 2021–2032 (USD MILLION)
TABLE 6 GLOBAL EYE ALLERGY TREATMENT MARKET, FOR CONTACT ALLERGIC CONJUNCTIVITIS, BY REGION, 2021–2032 (USD MILLION)
TABLE 7 GLOBAL EYE ALLERGY TREATMENT MARKET, FOR GIANT PAPILLARY CONJUNCTIVITIS, BY REGION, 2021–2032 (USD MILLION)
TABLE 8 GLOBAL EYE ALLERGY TREATMENT MARKET, BY DRUG CLASS, 2019–2032 (USD MILLION)
TABLE 9 GLOBAL EYE ALLERGY TREATMENT MARKET, FOR ANTIHISTAMINE, BY REGION, 2021–2032 (USD MILLION)
TABLE 10 GLOBAL EYE ALLERGY TREATMENT MARKET, FOR MAST CELL STABILIZER, BY REGION, 2021–2032 (USD MILLION)
TABLE 11 GLOBAL EYE ALLERGY TREATMENT MARKET, FOR NSAIDS, BY REGION, 2021–2032 (USD MILLION)
TABLE 12 GLOBAL EYE ALLERGY TREATMENT MARKET, FOR CORTICOSTEROID, BY REGION, 2021–2032 (USD MILLION)
TABLE 13 GLOBAL EYE ALLERGY TREATMENT MARKET, FOR DECONGESTANTS, BY REGION, 2021–2032 (USD MILLION)
TABLE 14 GLOBAL EYE ALLERGY TREATMENT MARKET, FOR IMMUNOTHERAPY ALLERGY SHOTS, BY REGION, 2021–2032 (USD MILLION)
TABLE 15 GLOBAL EYE ALLERGY TREATMENT MARKET, FOR IMMUNOTHERAPY ALLERGY SHOTS, BY TYPE, 2021–2032 (USD MILLION)
TABLE 16 GLOBAL EYE ALLERGY TREATMENT MARKET, FOR SUBCUTANEOUS IMMUNOTHERAPY ALLERGY SHOTS TREATMENT (SCIT), BY REGION, 2021–2032 (USD MILLION)
TABLE 17 GLOBAL EYE ALLERGY TREATMENT MARKET, FOR SUBLINGUAL IMMUNOTHERAPY ALLERGY SHOTS TREATMENT (SLIT), BY REGION, 2021–2032 (USD MILLION)
TABLE 18 GLOBAL EYE ALLERGY TREATMENT MARKET, FOR OTHERS, BY REGION, 2021–2032 (USD MILLION)
TABLE 19 GLOBAL EYE ALLERGY TREATMENT MARKET, BY TREATMENT FORM, 2019–2032 (USD MILLION)
TABLE 20 GLOBAL EYE ALLERGY TREATMENT MARKET, FOR EYEDROPS, BY REGION, 2021–2032 (USD MILLION)
TABLE 21 GLOBAL EYE ALLERGY TREATMENT MARKET, FOR INJECTABLES, BY REGION, 2021–2032 (USD MILLION)
TABLE 22 GLOBAL EYE ALLERGY TREATMENT MARKET, FOR TABLETS & CAPSULES, BY REGION, 2021–2032 (USD MILLION)
TABLE 23 GLOBAL EYE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)
TABLE 24 GLOBAL EYE ALLERGY TREATMENT MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2021–2032 (USD MILLION)
TABLE 25 GLOBAL EYE ALLERGY TREATMENT MARKET, FOR ONLINE PHARMACY, BY REGION, 2021–2032 (USD MILLION)
TABLE 26 GLOBAL EYE ALLERGY TREATMENT MARKET, FOR RETAIL PHARMACY, BY REGION, 2021–2032 (USD MILLION)
TABLE 27 GLOBAL EYE ALLERGY TREATMENT MARKET, BY REGION, 2019–2032 (USD MILLION)
TABLE 28 NORTH AMERICA: EYE ALLERGY TREATMENT MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
TABLE 29 NORTH AMERICA: EYE ALLERGY TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 30 NORTH AMERICA: EYE ALLERGY TREATMENT MARKET, BY DRUG CLASS, 2019–2032 (USD MILLION)
TABLE 31 NORTH AMERICA: EYE ALLERGY TREATMENT MARKET, FOR IMMUNOTHERAPY ALLERGY SHOTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 32 NORTH AMERICA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT FORM, 2019–2032 (USD MILLION)
TABLE 33 NORTH AMERICA: EYE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)
TABLE 34 US: EYE ALLERGY TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 35 US: EYE ALLERGY TREATMENT MARKET, BY DRUG CLASS, 2019–2032 (USD MILLION)
TABLE 36 US: EYE ALLERGY TREATMENT MARKET, FOR IMMUNOTHERAPY ALLERGY SHOTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 37 US: EYE ALLERGY TREATMENT MARKET, BY TREATMENT FORM, 2019–2032 (USD MILLION)
TABLE 38 US: EYE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)
TABLE 39 CANADA: EYE ALLERGY TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 40 CANADA: EYE ALLERGY TREATMENT MARKET, BY DRUG CLASS, 2019–2032 (USD MILLION)
TABLE 41 CANADA: EYE ALLERGY TREATMENT MARKET, FOR IMMUNOTHERAPY ALLERGY SHOTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 42 CANADA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT FORM, 2019–2032 (USD MILLION)
TABLE 43 CANADA: EYE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)
TABLE 44 EUROPE: EYE ALLERGY TREATMENT MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
TABLE 45 EUROPE: EYE ALLERGY TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 46 EUROPE: EYE ALLERGY TREATMENT MARKET, BY DRUG CLASS, 2019–2032 (USD MILLION)
TABLE 47 EUROPE: EYE ALLERGY TREATMENT MARKET, FOR IMMUNOTHERAPY ALLERGY SHOTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 48 EUROPE: EYE ALLERGY TREATMENT MARKET, BY TREATMENT FORM, 2019–2032 (USD MILLION)
TABLE 49 EUROPE: EYE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)
TABLE 50 GERMANY: EYE ALLERGY TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 51 GERMANY: EYE ALLERGY TREATMENT MARKET, BY DRUG CLASS, 2019–2032 (USD MILLION)
TABLE 52 GERMANY: EYE ALLERGY TREATMENT MARKET, FOR IMMUNOTHERAPY ALLERGY SHOTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 53 GERMANY: EYE ALLERGY TREATMENT MARKET, BY TREATMENT FORM, 2019–2032 (USD MILLION)
TABLE 54 GERMANY: EYE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)
TABLE 55 FRANCE: EYE ALLERGY TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 56 FRANCE: EYE ALLERGY TREATMENT MARKET, BY DRUG CLASS, 2019–2032 (USD MILLION)
TABLE 57 FRANCE: EYE ALLERGY TREATMENT MARKET, FOR IMMUNOTHERAPY ALLERGY SHOTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 58 FRANCE: EYE ALLERGY TREATMENT MARKET, BY TREATMENT FORM, 2019–2032 (USD MILLION)
TABLE 59 FRANCE: EYE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)
TABLE 60 UK: EYE ALLERGY TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 61 UK: EYE ALLERGY TREATMENT MARKET, BY DRUG CLASS, 2019–2032 (USD MILLION)
TABLE 62 UK: EYE ALLERGY TREATMENT MARKET, FOR IMMUNOTHERAPY ALLERGY SHOTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 63 UK: EYE ALLERGY TREATMENT MARKET, BY TREATMENT FORM, 2019–2032 (USD MILLION)
TABLE 64 UK: EYE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)
TABLE 65 ITALY: EYE ALLERGY TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 66 ITALY: EYE ALLERGY TREATMENT MARKET, BY DRUG CLASS, 2019–2032 (USD MILLION)
TABLE 67 ITALY: EYE ALLERGY TREATMENT MARKET, FOR IMMUNOTHERAPY ALLERGY SHOTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 68 ITALY: EYE ALLERGY TREATMENT MARKET, BY TREATMENT FORM, 2019–2032 (USD MILLION)
TABLE 69 ITALY: EYE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)
TABLE 70 SPAIN: EYE ALLERGY TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 71 SPAIN: EYE ALLERGY TREATMENT MARKET, BY DRUG CLASS, 2019–2032 (USD MILLION)
TABLE 72 SPAIN: EYE ALLERGY TREATMENT MARKET, FOR IMMUNOTHERAPY ALLERGY SHOTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 73 SPAIN: EYE ALLERGY TREATMENT MARKET, BY TREATMENT FORM, 2019–2032 (USD MILLION)
TABLE 74 SPAIN: EYE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)
TABLE 75 REST OF EUROPE: EYE ALLERGY TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 76 REST OF EUROPE: EYE ALLERGY TREATMENT MARKET, BY DRUG CLASS, 2019–2032 (USD MILLION)
TABLE 77 REST OF EUROPE: EYE ALLERGY TREATMENT MARKET, FOR IMMUNOTHERAPY ALLERGY SHOTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 78 REST OF EUROPE: EYE ALLERGY TREATMENT MARKET, BY TREATMENT FORM, 2019–2032 (USD MILLION)
TABLE 79 REST OF EUROPE: EYE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)
TABLE 80 ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
TABLE 81 ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 82 ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET, BY DRUG CLASS, 2019–2032 (USD MILLION)
TABLE 83 ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET, FOR IMMUNOTHERAPY ALLERGY SHOTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 84 ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET, BY TREATMENT FORM, 2019–2032 (USD MILLION)
TABLE 85 ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)
TABLE 86 CHINA: EYE ALLERGY TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 87 CHINA: EYE ALLERGY TREATMENT MARKET, BY DRUG CLASS, 2019–2032 (USD MILLION)
TABLE 88 CHINA: EYE ALLERGY TREATMENT MARKET, FOR IMMUNOTHERAPY ALLERGY SHOTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 89 CHINA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT FORM, 2019–2032 (USD MILLION)
TABLE 90 CHINA: EYE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)
TABLE 91 INDIA: EYE ALLERGY TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 92 INDIA: EYE ALLERGY TREATMENT MARKET, BY DRUG CLASS, 2019–2032 (USD MILLION)
TABLE 93 INDIA: EYE ALLERGY TREATMENT MARKET, FOR IMMUNOTHERAPY ALLERGY SHOTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 94 INDIA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT FORM, 2019–2032 (USD MILLION)
TABLE 95 INDIA: EYE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)
TABLE 96 JAPAN: EYE ALLERGY TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 97 JAPAN: EYE ALLERGY TREATMENT MARKET, BY DRUG CLASS, 2019–2032 (USD MILLION)
TABLE 98 JAPAN: EYE ALLERGY TREATMENT MARKET, FOR IMMUNOTHERAPY ALLERGY SHOTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 99 JAPAN: EYE ALLERGY TREATMENT MARKET, BY TREATMENT FORM, 2019–2032 (USD MILLION)
TABLE 100 JAPAN: EYE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)
TABLE 101 AUSTRALIA: EYE ALLERGY TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 102 AUSTRALIA: EYE ALLERGY TREATMENT MARKET, BY DRUG CLASS, 2019–2032 (USD MILLION)
TABLE 103 AUSTRALIA: EYE ALLERGY TREATMENT MARKET, FOR IMMUNOTHERAPY ALLERGY SHOTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 104 AUSTRALIA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT FORM, 2019–2032 (USD MILLION)
TABLE 105 AUSTRALIA: EYE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)
TABLE 106 SOUTH KOREA: EYE ALLERGY TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 107 SOUTH KOREA: EYE ALLERGY TREATMENT MARKET, BY DRUG CLASS, 2019–2032 (USD MILLION)
TABLE 108 SOUTH KOREA: EYE ALLERGY TREATMENT MARKET, FOR IMMUNOTHERAPY ALLERGY SHOTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 109 SOUTH KOREA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT FORM, 2019–2032 (USD MILLION)
TABLE 110 SOUTH KOREA: EYE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)
TABLE 111 REST OF ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 112 REST OF ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET, BY DRUG CLASS, 2019–2032 (USD MILLION)
TABLE 113 REST OF ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET, FOR IMMUNOTHERAPY ALLERGY SHOTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 114 REST OF ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET, BY TREATMENT FORM, 2019–2032 (USD MILLION)
TABLE 115 REST OF ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)
TABLE 116 REST OT THE WORLD: EYE ALLERGY TREATMENT MARKET, BY REGION, 2019–2032 (USD MILLION)
TABLE 117 REST OF THE WORLD: EYE ALLERGY TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 118 REST OF THE WORLD: EYE ALLERGY TREATMENT MARKET, BY DRUG CLASS, 2019–2032 (USD MILLION)
TABLE 119 REST OF THE WORLD: EYE ALLERGY TREATMENT MARKET, FOR IMMUNOTHERAPY ALLERGY SHOTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 120 REST OF THE WORLD: EYE ALLERGY TREATMENT MARKET, BY TREATMENT FORM, 2019–2032 (USD MILLION)
TABLE 121 REST OF THE WORLD: EYE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)
TABLE 122 MIDDLE EAST: EYE ALLERGY TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 123 MIDDLE EAST: EYE ALLERGY TREATMENT MARKET, BY DRUG CLASS, 2019–2032 (USD MILLION)
TABLE 124 MIDDLE EAST: EYE ALLERGY TREATMENT MARKET, FOR IMMUNOTHERAPY ALLERGY SHOTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 125 MIDDLE EAST: EYE ALLERGY TREATMENT MARKET, BY TREATMENT FORM, 2019–2032 (USD MILLION)
TABLE 126 MIDDLE EAST: EYE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)
TABLE 127 AFRICA: EYE ALLERGY TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 128 AFRICA: EYE ALLERGY TREATMENT MARKET, BY DRUG CLASS, 2019–2032 (USD MILLION)
TABLE 129 AFRICA: EYE ALLERGY TREATMENT MARKET, FOR IMMUNOTHERAPY ALLERGY SHOTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 130 AFRICA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT FORM, 2019–2032 (USD MILLION)
TABLE 131 AFRICA: EYE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)
TABLE 132 LATIN AMERICA: EYE ALLERGY TREATMENT MARKET, BY DRUG CLASS, 2019–2032 (USD MILLION)
TABLE 133 LATIN AMERICA: EYE ALLERGY TREATMENT MARKET, FOR IMMUNOTHERAPY ALLERGY SHOTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 134 LATIN AMERICA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT FORM, 2019–2032 (USD MILLION)
TABLE 135 LATIN AMERICA: EYE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION)
TABLE 136 PUBLIC PLAYERS STOCK SUMMARY
TABLE 137 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
TABLE 138 PRODUCT LAUNCH/ PRODUCT APPROVAL
TABLE 139 JOHNSON & JOHNSON SERVICES, INC: PRODUCTS OFFERED
TABLE 140 ABBVIE INC.: PRODUCTS OFFERED
TABLE 141 SUN PHARMACEUTICAL INDUSTRIES LTD.: PRODUCT OFFERED
TABLE 142 SUN PHARMACEUTICAL INDUSTRIES LTD.: KEY DEVELOPMENTS
TABLE 143 TEVA PHARMACEUTICAL INDUSTRIES LTD: PRODUCT OFFERED.
TABLE 144 TEVA PHARMACEUTICAL INDUSTRIES LTD: KEY DEVELOPMENTS
TABLE 145 HAL ALLERGY B.V.: PRODUCT OFFERED
TABLE 146 NOVARTIS AG: PRODUCT OFFERED
TABLE 147 BAUSCH + LOMB: PRODUCT OFFERED
TABLE 148 BAUSCH + LOMB: KEY DEVELOPMENTS
TABLE 149 SANTEN PHARMACEUTICAL CO., LTD.: PRODUCT OFFERED
TABLE 150 SANTEN PHARMACEUTICAL CO., LTD.: KEY DEVELOPMENTS
TABLE 151 ALCON: PRODUCT OFFERED
TABLE 152 ALCON: KEY DEVELOPMENTS
TABLE 153 BAYER AG: PRODUCT OFFERED
LIST OF FIGURES
FIGURE 1 GLOBAL EYE ALLERGY TREATMENT MARKET: STRUCTURE
FIGURE 2 GLOBAL EYE ALLERGY TREATMENT MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032)
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032)
FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL EYE ALLERGY TREATMENT MARKET
FIGURE 6 GLOBAL EYE ALLERGY TREATMENT MARKET; TYPE SEGMENT ATTRACTIVENESS, (USD MILLION)
FIGURE 7 GLOBAL EYE ALLERGY TREATMENT MARKET, BY TYPE, 2022 & 2032 (USD MILLION)
FIGURE 8 GLOBAL EYE ALLERGY TREATMENT MARKET SHARE (%), BY TYPE, 2022
FIGURE 9 GLOBAL EYE ALLERGY TREATMENT MARKET; DRUG CLASS SEGMENT ATTRACTIVENESS, (USD MILLION)
FIGURE 10 GLOBAL EYE ALLERGY TREATMENT MARKET, BY DRUG CLASS, 2022 & 2032 (USD MILLION)
FIGURE 11 GLOBAL EYE ALLERGY TREATMENT MARKET SHARE (%), BY DRUG CLASS, 2022
FIGURE 12 GLOBAL EYE ALLERGY TREATMENT MARKET; TREATMENT FORM SEGMENT ATTRACTIVENESS, (USD MILLION)
FIGURE 13 GLOBAL EYE ALLERGY TREATMENT MARKET, BY TREATMENT FORM, 2022 & 2032 (USD MILLION)
FIGURE 14 GLOBAL EYE ALLERGY TREATMENT MARKET SHARE (%), BY TREATMENT FORM, 2022
FIGURE 15 GLOBAL EYE ALLERGY TREATMENT MARKET; DISTRIBUTION CHANNEL SEGMENT ATTRACTIVENESS, (USD MILLION)
FIGURE 16 GLOBAL EYE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022 & 2032 (USD MILLION)
FIGURE 17 GLOBAL EYE ALLERGY TREATMENT MARKET SHARE (%), BY DISTRIBUTION CHANNEL, 2022
FIGURE 18 GLOBAL EYE ALLERGY TREATMENT MARKET, BY REGION, 2022 & 2032 (USD MILLION)
FIGURE 19 GLOBAL EYE ALLERGY TREATMENT MARKET SHARE (%), BY REGION, 2022
FIGURE 20 NORTH AMEICA MARKET ANALYSIS: EYE ALLERGY TREATMENT MARKET, 2019-2032 (USD MILLION)
FIGURE 21 NORTH AMERICA: EYE ALLERGY TREATMENT MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION)
FIGURE 22 NORTH AMERICA: EYE ALLERGY TREATMENT MARKET SHARE (%), BY COUNTRY, 2022
FIGURE 23 EUROPE MARKET ANALYSIS: EYE ALLERGY TREATMENT MARKET, 2019-2032 (USD MILLION)
FIGURE 24 EUROPE: EYE ALLERGY TREATMENT MARKET, BY REGION, 2022 & 2032 (USD MILLION)
FIGURE 25 EUROPE: EYE ALLERGY TREATMENT MARKET SHARE (%), BY REGION, 2022
FIGURE 26 ASIA-PACIFIC MARKET ANALYSIS: EYE ALLERGY TREATMENT MARKET, 2019-2032 (USD MILLION)
FIGURE 27 ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION)
FIGURE 28 ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET SHARE (%), BY COUNTRY, 2022
FIGURE 29 REST OF THE WORLD MARKET ANALYSIS: EYE ALLERGY TREATMENT MARKET, 2019-2032 (USD MILLION)
FIGURE 30 REST OT THE WORLD: EYE ALLERGY TREATMENT MARKET, BY REGION, 2022 & 2032 (USD MILLION)
FIGURE 31 REST OT THE WORLD: EYE ALLERGY TREATMENT MARKET SHARE (%), BY REGION, 2022
FIGURE 32 EYE ALLERGY TREATMENT MARKET PLAYERS: COMPETITIVE ANALSIS, 2022
FIGURE 33 COMPETITOR DASHBOARD: GLOBAL EYE ALLERGY TREATMENT MARKET
FIGURE 34 JOHNSON & JOHNSON SERVICES, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 35 JOHNSON & JOHNSON SERVICES, INC: SWOT ANALYSIS
FIGURE 36 ABBVIE INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 37 ABBVIE INC.: SWOT ANALYSIS
FIGURE 38 SUN PHARMACEUTICAL INDUSTRIES LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 39 SUN PHARMACEUTICAL INDUSTRIES LTD.: SWOT ANALYSIS
FIGURE 40 TEVA PHARMACEUTICAL INDUSTRIES LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 41 NOVARTIS AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 42 NOVARTIS AG.: SWOT ANALYSIS
FIGURE 43 BAUSCH + LOMB.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 44 BAUSCH + LOMB: SWOT ANALYSIS
FIGURE 45 SANTEN PHARMACEUTICAL CO., LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 46 ALCON: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 47 BAYER AG: FINANCIAL OVERVIEW SNAPSHOT
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們